The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: Comparison with DAT PET scans

Neuroscience Letters

Volumn 582, Issue , 2014, Pages 99-103

  Liu, Ping ^a   Li, Xin ^b   Li, Fang fei ^b   Ou Yang, Qiao hong ^c   Zhang, Hong xia ^b   Feng, Tao ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Computed tomography imaging; Dopamine transporter positron emission; Parkinson's disease; Substantia nigra; Transcranial sonography

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; CHINA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DOPAMINE TRANSPORTER IMAGING; ECHOENCEPHALOGRAPHY; FEMALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PARKINSON DISEASE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY; ULTRASOUND TRANSDUCER; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; BRAIN; COMPARATIVE STUDY; ECHOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SCINTISCANNING;

AGED; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGNOSIS;

EID: 84907402384     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.08.053     Document Type: Article

References (29)

1. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Felicio A.C., Shih M.C., Godeiro-Junior C., Andrade L.A., Bressan R.A., Ferraz H.B. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurologist 2009, 15:6-16.
3. Berg D. Transcranial sonography in the early and differential diagnosis of Parkinson's disease. J. Neural. Transm. Suppl. 2006, 249-254.
4. Berardelli A., Wenning G.K., Antonini A., Berg D., Bloem B.R., Bonifati V., Brooks D., Burn D.J., Colosimo C., Fanciulli A., Ferreira J., Gasser T., Grandas F., Kanovsky P., Kostic V., Kulisevsky J., Oertel W., Poewe W., Reese J.P., Relja M., Ruzicka E., Schrag A., Seppi K., Taba P., Vidailhet M. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur. J. Neurol. 2013, 20:16-34.
5. Bouwmans A.E., Vlaar A.M., Mess W.H., Kessels A., Weber W.E. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients. BMJ Open 2013, 3. pii:e002613.
6. Kagi G., Bhatia K.P., Tolosa E. The role of DAT-SPECT in movement disorders. J. Neurol. Neurosurg. Psychiatry 2010, 81:5-12.
7. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
8. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999, 53:1026-1031.
9. Walter U., Dressler D., Probst T., Wolters A., Abu-Mugheisib M., Wittstock M., Benecke R. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch. Neurol. 2007, 64:1635-1640.
10. Fahn S. Systemic therapy of dystonia. Can. J. Neurol. Sci. 1987, 14:528-532.
11. Becker G., Seufert J., Bogdahn U., Reichmann H., Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45:182-184.
12. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 2001, 248:684-689.
13. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J. Neural. Transm. 2002, 109:191-196.
14. Budisic M., Trkanjec Z., Bosnjak J., Lovrencic-Huzjan A., Vukovic V., Demarin V. Distinguishing Parkinson's disease and essential tremor with transcranial sonography. Acta Neurol. Scand. 2009, 119:17-21.
15. Vlaar A.M., de Nijs T., van Kroonenburgh M.J., Mess W.H., Winogrodzka A., Tromp S.C., Weber W.E. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol. 2008, 8:42.
16. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di Santo A., Schweitzer K.J., Gasser T., Machulla H.J., Reimold M., Marek K., Berg D. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 2008, 7:417-424.
17. Jennings D.L., Seibyl J.P., Oakes D., Eberly S., Murphy J., Marek K. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol. 2004, 61:1224-1229.
18. Meara J., Bhowmick B.K., Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999, 28:99-102.
19. Schrag A., Ben-Shlomo Y., Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community. J. Neurol. Neurosurg. Psychiatry 2002, 73:529-534.
20. Hughes A.J., Daniel S.E., Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001, 57:1497-1499.
21. Rajput A.H., Rozdilsky B., Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can. J. Neurol. Sci. 1991, 18:275-278.
22. Felicio A.C., Godeiro-Junior C., Shih M.C., Borges V., Silva S.M., Aguiar P.C., Hoexter M.Q., Barsottini O.G., Andrade L.A., Bressan R.A., Ferraz H.B. Evaluation of patients with clinically unclear Parkinsonian syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1. J. Neurol. Sci. 2010, 291:64-68.
23. Zubal I.G., Early M., Yuan O., Jennings D., Marek K., Seibyl J.P. Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients. J. Nucl. Med. 2007, 48:857-864.
24. Tsai C.F., Wu R.M., Huang Y.W., Chen L.L., Yip P.K., Jeng J.S. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism. J. Neurol. 2007, 254:501-507.
25. Weise D., Lorenz R., Schliesser M., Schirbel A., Reiners K., Classen J. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov. Disord. 2009, 24:1669-1675.
26. Berg D., Merz B., Reiners K., Naumann M., Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov. Disord. 2005, 20:383-385.
27. Schweitzer K.J., Hilker R., Walter U., Burghaus L., Berg D. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov. Disord. 2006, 21:94-98.
28. Huang Y.W., Jeng J.S., Tsai C.F., Chen L.L., Wu R.M. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov. Disord. 2007, 22:550-555.
29. Spiegel J., Hellwig D., Mollers M.O., Behnke S., Jost W., Fassbender K., Samnick S., Dillmann U., Becker G., Kirsch C.M. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006, 129:1188-1193.